Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2

Xuewei Wang1, Aritro Nath, Xuerui Yang

  • 1Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, Michigan, United States of America.

Plos One
|December 2, 2011
PubMed

Insights

Palmitate-induced liver cell damage involves gene interactions. This study identifies desmoplakin (DSP) as a key gene affected by palmitate, with insulin potentially restoring its expression, offering insights into non-alcoholic fatty liver disease (NAFLD).

Area of Science:

  • Cellular biology
  • Molecular biology
  • Biochemistry

Background:

  • Palmitate treatment in HepG2 cells induces cytotoxicity through complex gene interactions.
  • Previous research focused on individual genes, overlooking gene cooperativity in cellular responses.
  • Understanding gene networks is crucial for elucidating mechanisms of liver cell damage.

Purpose of the Study:

  • To reconstruct a gene-cooperativity network for palmitate-induced cytotoxicity in liver cells.
  • To identify key genes and pathways involved in palmitate-induced liver cell damage.
  • To explore the role of desmoplakin (DSP) and insulin signaling in this process.

Main Methods:

  • Applied information synergy to build a gene-cooperativity network.
  • Integrated gene expression and metabolic profile data for network reconstruction.
  • Analyzed the network to identify significantly enriched pathways and key gene neighbors.

Main Results:

  • Identified insulin signaling as the most significantly enriched pathway.
  • Desmoplakin (DSP) emerged as the top neighbor in the network.
  • Palmitate significantly reduced DSP expression, which was restored by insulin treatment.

Conclusions:

  • DSP expression is perturbed by palmitate, potentially contributing to liver cell cytotoxicity.
  • The findings suggest a link between palmitate, DSP, insulin resistance, and NAFLD pathogenesis.
  • DSP and insulin signaling pathways represent potential therapeutic targets for NAFLD.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...